Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.56 |
| ▸ | CDC25B | P30305 | 1/20 | 0.42 |
| ▸ | NFATC1 | O95644 | 1/20 | 0.40 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.40 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.39 |
| ▸ | TP53 | P04637 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | PTK2B | Q14289 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | GPR3 | P46089 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CASP1 | P29466 | 2/20 | 0.36 |
| ▸ | BLM | P54132 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29641696 | 0.85 | KMT2A (0.44) | MAOAMAOBCDC25BSMN1; SMN2TP53 | |
| SCHEMBL459050 | 0.85 | KMT2A (0.44) | MAOAMAOBCDC25BSMN1; SMN2TP53 | |
| SCHEMBL1103721 | 0.78 | MEN1 (0.44) | MAOAMAOBCDC25BDYRK1ASMN1; SMN2 | |
| SCHEMBL6774511 | 0.77 | MAOA (0.46) | MAOAMAOBCDC25BSMN1; SMN2TP53 | |
| SCHEMBL6775245 | 0.75 | MAOA (0.44) | MAOAMAOBCDC25BSLC22A12KDM4E | |
| SCHEMBL6781932 | 0.74 | MAPT (0.40) | MAOBSMN1; SMN2MAPTKDM4EGPR3 | |
| SCHEMBL421291 | 0.73 | MAOA (1.00) | MAOAMAOBCDC25BSMN1; SMN2TP53 | |
| SCHEMBL29350676 | 0.73 | MAOA (1.00) | MAOAMAOBCDC25BSMN1; SMN2TP53 | |
| SCHEMBL6775253 | 0.72 | MAOA (0.44) | MAOAMAOBSLC22A12SMN1; SMN2MAPT | |
| SCHEMBL6926901 | 0.72 | MAOA (0.95) | MAOAMAOBCDC25BSMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10907091-B2 | Organic compound and electrochromic element | CANON KABUSHIKI KAISHA (JP) | 2021-02-02 | — | — | US | disclosed |
| US-20190241798-A1 | ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2019-08-08 | — | — | US | disclosed |
| US-6680326-B2 | ANTITUMOR AGENTS; ANTICANCER AGENTS | HOFFMANN-LA ROCHE INC. | 2004-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10907091-B2 | Organic compound and electrochromic element | H1-2, H1-0, H1-10 | MAOA 898/4885MAOB 1031/4885CDC25B 1342/4885 |
| US-20190241798-A1 | ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT | H1-2, H1-0, H1-10 | MAOA 898/4885MAOB 1031/4885CDC25B 1342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.